Our study for DIHYDROBERBERINE has been adjusted to allow for adults up to 65 years of age (previously 55)
We have a new research study evaluating the effects of a dietary supplement on glucose and appetite response in adults.
Recent clinical studies suggest berberine may impact appetite-regulating hormones like glucagon-like peptide-1 (GLP-1); insulin sensitivity (how your body responds to the insulin in your blood); blood glucose levels and weight loss. Dihydroberberine (DHB), is a form of berberine that has the same characteristics as berberine but may be better absorbed by the body. The purpose of this research study is to evaluate the effect of a single dose of DHB and 6-weeks of DHB consumption versus placebo on various health outcomes.
The total study participation is approximately 8 weeks with 4 in-clinic visits. Three of the visits require you to be at the clinic for a 3-hour period. During the study, you’ll wear a continuous glucose monitor (CGM). Using a CGM requires you to wear a small sensor with a very thin filament that stays under your skin and constantly reads your blood sugar levels.
If qualified, you may be compensated up to $1,000 for completing all visits and study tasks.
Qualified participants must:
Be an adult between 35-65 years of age
Have a BMI ≥25 and ≤ 35 kg/m2
Be willing to attend three 3-hour visits with an IV catheter placed in the arm for multiple blood draws
Be willing to consume 4 capsules a day for 6 weeks, specifically 2 capsules in the morning and 2 capsules in the evening
Be willing to consume a vanilla flavored meal replacement drink
Be willing to wear a continuous glucose monitor
Be willing to download smart phone applications to track blood sugar and food and beverage intake
To see if you qualify, give us a call at 630-617-2000 or complete the survey below:
https://biofortis.clinicalconductor.com/CCEWeb/Forms/frmSurveyPreview.aspx?Direct=1&Mode=0&SurveyPKey=250&StudyPKey=6665
